icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Veropharm posts 9M 2010 Net Profit of 833.6 million Roubles

Veropharm posts 9M 2010 Net Profit of 833.6 million Roubles
Russian pharmaceutical maker, Veropharm, has posted a 9M 2010 Net profit of 833.6 million Roubles under IFRS.

The bottom line is up 14.1% on the 9M 2009 730.3 million rouble Net Profit, with EBITDA up 17.1% year on year to 1.1billion roubles, as Revenues rose 22.4% to 3.9 billion roubles from 3.2 billion roubles a year earlier.According to the accompanying statement, higher sales were mostly due to growing share of Rx drugs, which reached 70% of total sales. The Company also noted that domestic trade accounted for 96.3% of the Company’s total finished goods sales for the reporting period.

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.

Podcasts